Alisa Goldstein Retires from the NIH
Alisa Goldstein, Ph.D.
Alisa M. Goldstein, Ph.D., senior investigator in the Clinical Genetics Branch, retired from the NCI in 2026 after 37 years of service. Dr. Goldstein is an internationally recognized expert in the genetic etiology of melanoma, chordoma, and upper gastrointestinal cancer.
Through understanding the causes of cancer, her long-term studies have helped to improve disease detection and clinical care of genetically at-risk individuals, refine high-risk groups for improved screening and surveillance, and outline modifiable risk factors that could contribute to cancer prevention and therapeutic development.
Over the course of her career, she co-authored more than 360 papers focusing on genetic epidemiologic studies of familial and pediatric melanoma with Drs. Margaret Tucker, Rose Yang, Michael Sargen, Maria Teresa Landi, and the Melanoma Genetics Consortium; familial and sporadic chordoma with Drs. Dilys Parry and Rose Yang; upper gastrointestinal cancer with Drs. Nan Hu , Phil Taylor, and the Shanxi Cancer Institute; nasopharyngeal cancer with Dr. Allan Hildesheim and the National Taiwan University; and methodologic studies with Dr. Nadine Andrieu.
Dr. Goldstein served as president of the International Genetic Epidemiology Society (IGES) in 2011. Her commitment to mentoring was recognized with the NCI Women Scientists Advisors (WSA) Mentoring and Leadership award (2013).